Difficulty: Medium
Average Score: 86%
Practice
A 56-year-old man presents to his primary care physician complaining of difficulty urinating. Digital rectal exam reveals an enlarged prostate. The patient is started on a trial of terazosin, after which his symptoms improve dramatically. Which of the following describes terazosin's drug class?
Correct answer
A
Rationale
Terazosin belongs to the drug class of ╬▒1-adrenergic antagonists. These drugs work by blocking the ╬▒1-adrenergic receptors, leading to vasodilation of both arteries and veins. In the case of an enlarged prostate, terazosin helps relax the smooth muscle in the prostate and bladder neck, improving urinary flow.
Option A is correct because terazosin specifically targets ╬▒1-adrenergic receptors. Option B, ╬▒1ÔÇÜÔÇÜ-adrenergic antagonist, is incorrect as there is no such drug class. Option C, anticholinergic drugs, work by blocking acetylcholine receptors and are not related to terazosin's mechanism of action. Option D, ├ƒ2ÔÇÜÔÇÜ-adrenergic agonists, target different adrenergic receptors and are not relevant to terazosin's function in this scenario.
Understanding the pharmacology of cardiovascular drugs like terazosin is essential for healthcare professionals to make informed decisions in managing conditions like benign prostatic hyperplasia. By grasping the specific mechanisms of action of different drug classes, practitioners can optimize patient care and outcomes.
Option A is correct because terazosin specifically targets ╬▒1-adrenergic receptors. Option B, ╬▒1ÔÇÜÔÇÜ-adrenergic antagonist, is incorrect as there is no such drug class. Option C, anticholinergic drugs, work by blocking acetylcholine receptors and are not related to terazosin's mechanism of action. Option D, ├ƒ2ÔÇÜÔÇÜ-adrenergic agonists, target different adrenergic receptors and are not relevant to terazosin's function in this scenario.
Understanding the pharmacology of cardiovascular drugs like terazosin is essential for healthcare professionals to make informed decisions in managing conditions like benign prostatic hyperplasia. By grasping the specific mechanisms of action of different drug classes, practitioners can optimize patient care and outcomes.